Healthy Extracts Acquires Imaraï's Beauty Brand, Appoints Founder as Chief Brand Officer
HYEX sits 56% above its 52-week low of $0.805 on light trading volume (0.2× avg).
Summary
Healthy Extracts Inc. acquired Adli Gummies Inc. and its Imaraï's Beauty brand for $4.55 million, with no net equity dilution due to a CEO share cancellation, and appointed Adli's founder as Chief Brand Officer.
Key Events · M&A and Partnerships · HYEX
-
Acquisition of Adli Gummies Inc. and Imaraï's Beauty Brand
Healthy Extracts acquired Adli Gummies Inc. for $794,000 in secured promissory notes and 3,000,000 shares (or exchangeable shares). The total transaction value is approximately $4.55 million.
-
No Net Equity Dilution for Existing Shareholders
CEO Donald Swanson cancelled 3,000,000 shares of his common stock, offsetting the shares issued in the acquisition and resulting in no net dilution for existing shareholders from the equity component.
-
New Chief Brand Officer Appointed
Aaron Hefter, founder of Adli Gummies Inc., was appointed as Chief Brand Officer, bringing over two decades of experience in the nutraceutical and wellness industries.
-
Strategic Growth
This acquisition expands Healthy Extracts' product portfolio in the rapidly growing ingestible beauty and wellness sector, aligning with the company's recent strong revenue growth.
Analysis · HYEX · Life Sciences
Healthy Extracts Inc. has completed a significant acquisition of Adli Gummies Inc. and its Imaraï's Beauty brand, valued at approximately $4.55 million, which is over 21% of its market capitalization. The deal is structured with a combination of cash and equity, notably featuring a share cancellation by CEO Donald Swanson that results in no net dilution from the equity component for existing shareholders. This demonstrates strong management conviction in the acquisition. The appointment of Adli's founder, Aaron Hefter, as Chief Brand Officer brings extensive industry expertise, which is crucial for integrating and growing the new brand. This strategic move aims to bolster the company's product portfolio and leadership, building on recent strong revenue growth.
How filings like this one have moved
In the 30 days to Aug 25, 2026, 43.9% of the 999 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.15%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HYEX was trading at $1.25 on OTC in the Life Sciences sector, with a market capitalization of approximately $21.2M. The 52-week trading range was $0.81 to $4.29. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.